Literature DB >> 22282453

A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Kim T Mueser1, Shirley M Glynn, Corrine Cather, Haiyi Xie, Roberto Zarate, Lindy Fox Smith, Robin E Clark, Jennifer D Gottlieb, Rosemarie Wolfe, James Feldman.   

Abstract

Substance use disorders have a profound impact on the course of severe mental illnesses and on the family, but little research has evaluated the impact of family intervention for this population. To address this question, a randomized controlled trial was conducted comparing a brief (2-3 mo) Family Education (ED) program with a longer-term (9-18 mo) program that combined education with teaching communication and problem-solving skills, Family Intervention for Dual Disorders (FIDD). A total of 108 clients (77% schizophrenia-spectrum) and a key relative were randomized to either ED or FIDD and assessed at baseline and every 6 months for 3 years. Rates of retention of families in both programs were moderate. Intent-to-treat analyses indicated that clients in both programs improved in psychiatric, substance abuse, and functional outcomes, as did key relatives in knowledge of co-occurring disorders, burden, and mental health functioning. Clients in FIDD had significantly less severe overall psychiatric symptoms and psychotic symptoms and tended to improve more in functioning. Relatives in FIDD improved more in mental health functioning and knowledge of co-occurring disorders. There were no consistent differences between the programs in substance abuse severity or family burden. The findings support the utility of family intervention for co-occurring disorders, and the added benefits of communication and problem-solving training, but also suggest the need to modify these programs to retain more families in treatment in order to provide them with the information and skills they need to overcome the effects of these disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22282453      PMCID: PMC3627753          DOI: 10.1093/schbul/sbr203

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  46 in total

1.  A family intervention program for dual disorders.

Authors:  Kim T Mueser; Lindy Fox
Journal:  Community Ment Health J       Date:  2002-06

2.  Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia.

Authors:  M P Salyers; K T Mueser
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

3.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

4.  Unbalanced repeated-measures models with structured covariance matrices.

Authors:  R I Jennrich; M D Schluchter
Journal:  Biometrics       Date:  1986-12       Impact factor: 2.571

5.  Family support and substance use outcomes for persons with mental illness and substance use disorders.

Authors:  R E Clark
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

6.  Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse. 18-month outcomes of a randomised controlled trial.

Authors:  Gillian Haddock; Christine Barrowclough; Nicholas Tarrier; Jan Moring; Robert O'Brien; Nichola Schofield; Joanne Quinn; Steven Palmer; Linda Davies; Ian Lowens; John McGovern; Shôn Lewis
Journal:  Br J Psychiatry       Date:  2003-11       Impact factor: 9.319

7.  Family educational intervention in the treatment of schizophrenia.

Authors:  C W McGill; I R Falloon; J L Boyd; C Wood-Siverio
Journal:  Hosp Community Psychiatry       Date:  1983-10

8.  A brief motivational intervention for substance misuse in recent-onset psychosis.

Authors:  David J Kavanagh; Ross Young; Angela White; John B Saunders; Jeff Wallis; Natalie Shockley; Linda Jenner; Anne Clair
Journal:  Drug Alcohol Rev       Date:  2004-06

9.  Impact of multiple-family groups for outpatients with schizophrenia on caregivers' distress and resources.

Authors:  Nicholas A Hazel; Michael G McDonell; Robert A Short; Christopher M Berry; William D Voss; Martina L Rodgers; Dennis G Dyck
Journal:  Psychiatr Serv       Date:  2004-01       Impact factor: 3.084

10.  Family management in the prevention of morbidity of schizophrenia: social outcome of a two-year longitudinal study.

Authors:  I R Falloon; C W McGill; J L Boyd; J Pederson
Journal:  Psychol Med       Date:  1987-02       Impact factor: 7.723

View more
  13 in total

Review 1.  Psychoeducation for schizophrenia.

Authors:  Jun Xia; Lars Bertil Merinder; Madhvi R Belgamwar
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

2.  Family interventions in Schizophrenia: promise and pitfalls over 30 years.

Authors:  Shirley M Glynn
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

3.  Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.

Authors:  Shaun M Eack; Susan S Hogarty; Deborah P Greenwald; Maralee Y Litschge; Summer A F McKnight; Srihari S Bangalore; Michael F Pogue-Geile; Matcheri S Keshavan; Jack R Cornelius
Journal:  Schizophr Res       Date:  2014-12-12       Impact factor: 4.939

4.  Substance Use in Relation to Mental Illness: A Study of Mexican-Origin Latinos with Schizophrenia and Their Family Members.

Authors:  Mercedes Hernandez; Concepcion Barrio; Paula Helu-Brown; Caroline Lim; Lizbeth Gaona
Journal:  Health Soc Work       Date:  2022-07-13

5.  Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.

Authors:  Robert K Brooner; Michael S Kidorf; Van L King; Jessica Peirce; Karin Neufeld; Ken Stoller; Ken Kolodner
Journal:  Addiction       Date:  2013-07-19       Impact factor: 6.526

6.  Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.

Authors:  Cristina Aydin; Philip G Tibbo; Zenovia Ursuliak
Journal:  Can J Psychiatry       Date:  2016-03-16       Impact factor: 4.356

7.  Caregiving for Relatives with Psychiatric Disorders vs. Co-Occurring Psychiatric and Substance Use Disorders.

Authors:  Travis Labrum
Journal:  Psychiatr Q       Date:  2018-09

8.  Trans-Sector Integrated Treatment in Psychosis and Addiction.

Authors:  Euphrosyne Gouzoulis-Mayfrank; Susanne König; Stefan Koebke; Thomas Schnell; Mario Schmitz-Buhl; Jörg Daumann
Journal:  Dtsch Arztebl Int       Date:  2015-10-09       Impact factor: 5.594

Review 9.  Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults.

Authors:  Amber Edinoff; Miriam T Ruoff; Yahya T Ghaffar; Arthur Rezayev; Devanshi Jani; Adam M Kaye; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2020-09-14

10.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Carrie Brooke-Sumner; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.